The metformin recalls that have plagued the diabetes drug industry for the past year continue as yet another company’s formulation of the drug has tested positive for a human carcinogen.
The debacle started in 2020 when lots of metformin from Teva Pharmaceuticals and Sun Pharmaceuticals both tested positive for NDMA, or N-Nitrosodimethylamine. The compound is believed to have ties to variety of types of cancer and the discovery was enough to trigger recalls ...
continue reading...
Two lots of diabetes drug metformin produced by Kansas City, Missouri drug maker Nostrum Laboratories are being pulled from pharmacy shelves over concerns that they might be contaminated with a cancer-causing compound. The compound, known as NDMA or nitrosamine, was detected in the company’s 750mg HCI extended-release tablets at levels that exceed federal regulations.
NDMA is a naturally occurring chemical that is found in everything from the fruits ...
continue reading...
Diabetics who take metformin will want to contact their healthcare providers after multiple recalls of the drug have occurred due to the discovery of elevated levels of a cancer-causing compound. Multiple lots of the extended release version of the drug from multiple manufacturers tested positive for the presence of NDMA, or N-Nitrosodimethylamine, in amounts that exceed FDA regulations.
According to the FDA, humans should be able to tolerate ...
continue reading...
Plaintiffs in valsartan-based drug lawsuits filed over possible carcinogenic contamination may have to make room for additional consumers as lawyers push for the inclusion of two other blood pressure medications, losartan and irbesartan. Batches of the drugs, in addition to valsartan, have been found to be tainted with NDMA, or nitrosodimethylamine. NDMA is a known human carcinogen and has been linked to the development of certain ...
